Park National Corp Abbott Laboratories Transaction History

Park National Corp

$2.57 Billion
Q1 2024

A detailed history of Park National Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Park National Corp holds 312,738 shares of ABT stock, worth $32.5 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares

312,738

Previous 338,920 7.73%

Holding current value

$32.5 Million

Previous $37.3 Million 4.72%

% of portfolio

1.38%

Previous 1.54%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 01, 2024	SELL	$109.52 - $120.96 $2.87 Million - $3.17 Million	-26,182 Reduced 7.73%	312,738 $35.5 Million
Q4 2023 Jan 02, 2024	SELL	$90.19 - $110.4 $2.86 Million - $3.5 Million	-31,690 Reduced 8.55%	338,920 $37.3 Million
Q3 2023 Oct 02, 2023	SELL	$95.53 - $114.62 $765,864 - $918,908	-8,017 Reduced 2.12%	370,610 $35.9 Million
Q2 2023 Jul 03, 2023	SELL	$100.78 - $112.29 $1.2 Million - $1.34 Million	-11,941 Reduced 3.06%	378,627 $41.3 Million
Q1 2023 Apr 03, 2023	SELL	$96.86 - $114.01 $924,625 - $1.09 Million	-9,546 Reduced 2.39%	390,568 $39.5 Million

Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $1.59 Million - $1.86 Million	-16,701 Reduced 4.01%	400,114 $43.9 Million
Q3 2022 Oct 03, 2022	BUY	$96.76 - $112.03 $3.63 Million - $4.2 Million	37,507 Added 9.89%	416,815 $40.3 Million
Q2 2022 Jul 01, 2022	SELL	$102.07 - $123.37 $275,793 - $333,345	-2,702 Reduced 0.71%	379,308 $41.2 Million
Q1 2022 Apr 01, 2022	SELL	$114.02 - $139.04 $315,037 - $384,167	-2,763 Reduced 0.72%	382,010 $45.2 Million
Q4 2021 Jan 04, 2022	SELL	$115.53 - $141.46 $3.47 Million - $4.25 Million	-30,070 Reduced 7.25%	384,773 $54.2 Million
Q3 2021 Oct 01, 2021	SELL	$116.66 - $129.06 $2.23 Million - $2.47 Million	-19,136 Reduced 4.41%	414,843 $49 Million
Q2 2021 Jul 01, 2021	SELL	$105.79 - $124.53 $1.92 Million - $2.26 Million	-18,178 Reduced 4.02%	433,979 $50.3 Million
Q1 2021 Apr 01, 2021	SELL	$108.84 - $128.23 $4.27 Million - $5.03 Million	-39,207 Reduced 7.98%	452,157 $54.2 Million
Q4 2020 Jan 04, 2021	SELL	$105.0 - $114.42 $920,955 - $1 Million	-8,771 Reduced 1.75%	491,364 $53.8 Million
Q3 2020 Oct 01, 2020	SELL	$91.64 - $111.29 $1.54 Million - $1.87 Million	-16,833 Reduced 3.26%	500,135 $54.4 Million
Q2 2020 Jul 01, 2020	SELL	$76.57 - $98.0 $1.22 Million - $1.56 Million	-15,966 Reduced 3.0%	516,968 $47.3 Million
Q1 2020 Apr 01, 2020	SELL	$62.82 - $91.86 $811,571 - $1.19 Million	-12,919 Reduced 2.37%	532,934 $42.1 Million
Q4 2019 Jan 02, 2020	BUY	$78.51 - $87.4 $247,227 - $275,222	3,149 Added 0.58%	545,853 $47.4 Million
Q3 2019 Oct 01, 2019	SELL	$81.84 - $88.74 $8,511 - $9,228	-104 Reduced 0.02%	542,704 $45.4 Million
Q2 2019 Jul 01, 2019	SELL	$72.88 - $85.0 $522,768 - $609,705	-7,173 Reduced 1.3%	542,808 $45.7 Million
Q1 2019 Apr 01, 2019	SELL	$66.22 - $80.06 $188,991 - $228,491	-2,854 Reduced 0.52%	549,981 $44 Million
Q4 2018 Jan 02, 2019	SELL	$65.56 - $74.27 $68,969 - $78,132	-1,052 Reduced 0.19%	552,835 $40 Million
Q3 2018 Oct 02, 2018	BUY	$60.81 - $73.36 $252,300 - $304,370	4,149 Added 0.75%	553,887 $40.6 Million
Q2 2018 Jul 02, 2018	SELL	$57.57 - $63.54 $326,249 - $360,081	-5,667 Reduced 1.02%	549,738 $33.5 Million
Q1 2018 Apr 02, 2018	SELL	$56.27 - $63.62 $1.54 Million - $1.74 Million	-27,404 Reduced 4.7%	555,405 $33.3 Million
Q4 2017 Jan 02, 2018	SELL	$53.68 - $57.47 $1.04 Million - $1.12 Million	-19,427 Reduced 3.23%	582,809 $33.3 Million
Q3 2017 Oct 02, 2017	BUY	$48.06 - $53.64 $28.9 Million - $32.3 Million	602,236	602,236 $32.1 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Account

Park National Corp Abbott Laboratories Transaction History